Uric acid in metabolic syndrome: From an innocent bystander to a central player

European Journal of Internal Medicine

Volumn 29, Issue , 2016, Pages 3-8

  Kanbay, Mehmet ^a   Jensen, Thomas ^b   Solak, Yalcin ^c   Le, Myphuong ^b   Roncal Jimenez, Carlos ^b   Rivard, Chris ^b   Lanaspa, Miguel A ^b   Nakagawa, Takahiko ^d   Johnson, Richard J ^b,e  

^a KOÇ UNIVERSITY   (Turkey)

^b UNIVERSITY OF COLORADO   (United States)

^c Sakarya Education and Research Hospital   (Turkey)

^d KYOTO UNIVERSITY   (Japan)

^e Eastern Colorado Health Care System   (United States)

Author keywords

Cardiovascular disease; Diabetes mellitus; Hypertension; Kidney disease; Metabolic syndrome; Uric acid

Indexed keywords

URIC ACID;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIET; DISEASE ACTIVITY; HUMAN; HYPERTENSION; LIPID STORAGE; LIVER; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OUTCOME ASSESSMENT; PURINE METABOLISM; REVIEW; RISK FACTOR; BLOOD; CHRONIC KIDNEY FAILURE; HYPERURICEMIA;

DIABETES MELLITUS; HUMANS; HYPERTENSION; HYPERURICEMIA; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID;

EID: 84950282194     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.11.026     Document Type: Review

References (117)

1. R.J. Johnson, P. Stenvinkel, S.L. Martin, A. Jani, L.G. Sanchez-Lozada, J.O. Hill, and et al. Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology Obesity 21 4 2013 659 664
2. M.A. Lanaspa, C. Cicerchi, G. Garcia, N. Li, C.A. Roncal-Jimenez, C.J. Rivard, and et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver PLoS One 7 11 2012 e48801
3. C. Cicerchi, N. Li, J. Kratzer, G. Garcia, C.A. Roncal-Jimenez, K. Tanabe, and et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids FASEB J 28 8 2014 3339 3350
4. M.A. Lanaspa, E. Epperson, N. Li, C. Cicerchi, G. Garcia, C. Roncal-Jimenez, and et al. Opposing activity changes in AMP deaminase and AMP-activated protein kinase in the hibernating ground squirrel PLoS One 10 4 2015 e0123509
5. M.A. Lanaspa, L.G. Sanchez-Lozada, Y.J. Choi, C. Cicerchi, M. Kanbay, C.A. Roncal-Jimenez, and et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver J Biol Chem 287 48 2012 40732 40744
6. Y.J. Choi, H.S. Shin, H.S. Choi, J.W. Park, I. Jo, E.S. Oh, and et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes Lab Invest 94 10 2014 1114 1125
7. F.A. Mahomed The etiology of Bright's disease and the prealbuminuric state Med Chir Trans 39 1874 197 228
8. A. Haig The connecting link between the high tension pulse and albuminuria Br Med J 1 1890 65 68
9. N.C. Davis The cardiovascular and renal relations and manifestations of gout JAMA 29 1897 261 262
10. P.J. Cannon, W.B. Stason, F.E. Demartini, S.C. Sommers, and J.H. Laragh Hyperuricemia in primary and renal hypertension N Engl J Med 275 9 1966 457 464
11. D.I. Feig, and R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 3 2003 247 252
12. R.J. Johnson, S. Titte, J.R. Cade, B.A. Rideout, and W.J. Oliver Uric acid, evolution and primitive cultures Semin Nephrol 25 1 2005 3 8
13. M. Mazzali, J. Hughes, Y.G. Kim, J.A. Jefferson, D.H. Kang, K.L. Gordon, and et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism Hypertension 38 5 2001 1101 1106
14. B.J. DeBosch, O. Kluth, H. Fujiwara, A. Schurmann, and K. Moley Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9 Nat Commun 5 2014 4642
15. L.G. Sanchez-Lozada, T. Nakagawa, D.H. Kang, D.I. Feig, M. Franco, R.J. Johnson, and et al. Hormonal and cytokine effects of uric acid Curr Opin Nephrol Hypertens 15 1 2006 30 33
16. W. Baldwin, S. McRae, G. Marek, D. Wymer, V. Pannu, C. Baylis, and et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome Diabetes 60 4 2011 1258 1269
17. S. Watanabe, D.H. Kang, L. Feng, T. Nakagawa, J. Kanellis, H. Lan, and et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity Hypertension 40 3 2002 355 360
18. B. Soletsky, and D.I. Feig Uric acid reduction rectifies prehypertension in obese adolescents Hypertension 60 5 2012 1148 1156
19. D.I. Feig, B. Soletsky, and R.J. Johnson Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial JAMA 300 8 2008 924 932
20. F. Assadi Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension J Nephrol 27 1 2014 51 56
21. M. Kanbay, B. Huddam, A. Azak, Y. Solak, G.K. Kadioglu, I. Kirbas, and et al. A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function Clin J Am Soc Nephrol 6 8 2011 1887 1894
22. M. Kanbay, A. Ozkara, Y. Selcoki, B. Isik, F. Turgut, N. Bavbek, and et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions Int Urol Nephrol 39 4 2007 1227 1233
23. P. Higgins, M.R. Walters, H.M. Murray, K. McArthur, A. McConnachie, K.R. Lees, and et al. Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial Heart 100 14 2014 1085 1092
24. C.J. Beattie, R.L. Fulton, P. Higgins, S. Padmanabhan, L. McCallum, M.R. Walters, and et al. Allopurinol initiation and change in blood pressure in older adults with hypertension Hypertension 64 5 2014 1102 1107
25. H.A. Kim, Y.I. Seo, and Y.W. Song Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men J Korean Med Sci 29 8 2014 1077 1081
26. M. Madero, F.E. Rodriguez Castellanos, D. Jalal, M. Villalobos-Martin, J. Salazar, A. Vazquez-Rangel, and et al. A pilot study on the impact of a low fructose diet and allopurinol on clinic blood pressure among overweight and prehypertensive subjects: a randomized placebo controlled trial J Am Soc Hypertens 9 11 2015 837 844
27. B.H. Pai, G. Swarnalatha, R. Ram, and K.V. Dakshinamurty Allopurinol for prevention of progression of kidney disease with hyperuricemia Indian J Nephrol. 23 4 2013 280 286
28. M. Jalalzadeh, Z. Nurcheshmeh, R. Mohammadi, N. Mousavinasab, and M.H. Ghadiani The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia J Res Med Sci 17 11 2012 1039 1046
29. M. Goicoechea, S.G. de Vinuesa, U. Verdalles, C. Ruiz-Caro, J. Ampuero, A. Rincon, and et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk Clin J Am Soc Nephrol 5 8 2010 1388 1393
30. U.M. Khosla, S. Zharikov, J.L. Finch, T. Nakagawa, C. Roncal, W. Mu, and et al. Hyperuricemia induces endothelial dysfunction Kidney Int 67 5 2005 1739 1742
31. C. Gersch, S.P. Palii, K.M. Kim, A. Angerhofer, R.J. Johnson, and G.N. Henderson Inactivation of nitric oxide by uric acid Nucleosides Nucleotides Nucleic Acids 27 8 2008 967 978
32. S. Zharikov, K. Krotova, H. Hu, C. Baylis, R.J. Johnson, E.R. Block, and et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells Am J Physiol Cell Physiol 295 5 2008 C1183 C1190
33. I.F. Schwartz, A. Grupper, T. Chernichovski, O. Hillel, A. Engel, and D. Schwartz Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats J Vasc Res 48 3 2011 252 260
34. L.G. Sanchez-Lozada, M.A. Lanaspa, M. Cristobal-Garcia, F. Garcia-Arroyo, V. Soto, D. Cruz-Robles, and et al. Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations Nephron Exp Nephrol 121 3-4 2012 e71 e78
35. L.G. Sanchez-Lozada, E. Tapia, R. Lopez-Molina, T. Nepomuceno, V. Soto, C. Avila-Casado, and et al. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia Am J Physiol Renal Physiol 292 4 2007 F1238 F1244
36. M. Mazzali, J. Kanellis, L. Han, L. Feng, Y.Y. Xia, Q. Chen, and et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol Renal Physiol 282 6 2002 F991 F997
37. H.H. Chao, J.C. Liu, J.W. Lin, C.H. Chen, C.H. Wu, and T.H. Cheng Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells Acta Pharmacol Sin 29 11 2008 1301 1312
38. T.H. Cheng, J.W. Lin, H.H. Chao, Y.L. Chen, C.H. Chen, P. Chan, and et al. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts Int J Cardiol 139 1 2010 42 49
39. D.H. Kang, S.K. Park, I.K. Lee, and R.J. Johnson Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells J Am Soc Nephrol 16 12 2005 3553 3562
40. M.A. Yu, L.G. Sanchez-Lozada, R.J. Johnson, and D.H. Kang Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction J Hypertens 28 6 2010 1234 1242
41. Y.Y. Sautin, T. Nakagawa, S. Zharikov, and R.J. Johnson Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress Am J Physiol Cell Physiol 293 2 2007 C584 C596
42. D.B. Corry, P. Eslami, K. Yamamoto, M.D. Nyby, H. Makino, and M.L. Tuck Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system J Hypertens 26 2 2008 269 275
43. L.G. Sanchez-Lozada, C. Rivard, M. Lanaspa, C. Roncal, M. Franco, Y. Sautin, and et al. Uric acid alters mitochondrial biogenesis in cultured human endothelial cells Am Soc Nephrol Annual Meeting 2009 (abstract)
44. L.G. Sanchez-Lozada, V. Soto, E. Tapia, C. Avila-Casado, Y.Y. Sautin, T. Nakagawa, and et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia Am J Physiol Renal Physiol 295 4 2008 F1134 F1141
45. G.N. Rao, M.A. Corson, and B.C. Berk Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression J Biol Chem 266 13 1991 8604 8608
46. J. Kanellis, S. Watanabe, J.H. Li, D.H. Kang, P. Li, T. Nakagawa, and et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 Hypertension 41 6 2003 1287 1293
47. D. Duckworth A treatise on gout 1889 C Griffin & Co London (476 pp.)
48. E. Kylin Studien uber das hypertonie-hyperglykamie-hyperurikamiesyndrome Studies of the hypertension-hyperglycemia-hyperuricemia syndrome Zbl inn Med 44 1923 105 127
49. R.J. Johnson, T. Nakagawa, L.G. Sanchez-Lozada, M. Shafiu, S. Sundaram, M. Le, and et al. Sugar, uric acid, and the etiology of diabetes and obesity Diabetes 62 10 2013 3307 3315
50. F. Facchini, Y.D. Chen, C.B. Hollenbeck, and G.M. Reaven Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration JAMA 266 21 1991 3008 3011
51. E. Krishnan, B.J. Pandya, L. Chung, A. Hariri, and O. Dabbous Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study Am J Epidemiol 176 2 2012 108 116
52. S. Cook, O. Hugli, M. Egli, P. Vollenweider, R. Burcelin, P. Nicod, and et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice Swiss Med Wkly 133 25-26 2003 360 363
53. C.A. Roncal-Jimenez, M.A. Lanaspa, C.J. Rivard, T. Nakagawa, L.G. Sanchez-Lozada, D. Jalal, and et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake Metab Clin Exp 60 9 2011 1259 1270
54. F.W. Scott, K.D. Trick, B. Stavric, J.T. Braaten, and Y. Siddiqui Uric acid-induced decrease in rat insulin secretion Proc Soc Exp Biol Med 166 1 1981 123 128
55. K. Ogino, M. Kato, Y. Furuse, Y. Kinugasa, K. Ishida, S. Osaki, and et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study Circ Heart Fail 3 1 2010 73 81
56. C. Facchini, G. Malfatto, A. Giglio, M. Facchini, G. Parati, and G. Branzi Lung ultrasound and transthoracic impedance for noninvasive evaluation of pulmonary congestion in heart failure J Cardiovasc Med 2015 (in press)
57. A. Dogan, M. Yarlioglues, M.G. Kaya, Z. Karadag, S. Dogan, I. Ardic, and et al. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients Blood Press 20 3 2011 182 187
58. R. Pfister, D. Barnes, R. Luben, N.G. Forouhi, M. Bochud, K.T. Khaw, and et al. No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach Diabetologia 54 10 2011 2561 2569
59. Q. Yang, A. Kottgen, A. Dehghan, A.V. Smith, N.L. Glazer, M.H. Chen, and et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors Circ Cardiovasc Genet 3 6 2010 523 530
60. R.J. Johnson, T. Merriman, and M.A. Lanaspa Causal or noncausal relationship of uric acid with diabetes Diabetes 64 8 2015 2720 2722
61. K. Masuo, H. Kawaguchi, H. Mikami, T. Ogihara, and M.L. Tuck Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation Hypertension 42 4 2003 474 480
62. J.C. Sirota, K. McFann, G. Targher, R.J. Johnson, M. Chonchol, and D.I. Jalal Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey Metab Clin Exp 62 3 2013 392 399
63. J.W. Lee, Y.K. Cho, M. Ryan, H. Kim, S.W. Lee, E. Chang, and et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study Gut Liver 4 3 2010 378 383
64. A. Lonardo, P. Loria, F. Leonardi, A. Borsatti, P. Neri, M. Pulvirenti, and et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study Dig Liver Dis 34 3 2002 204 211
65. S. Petta, C. Camma, D. Cabibi, V. Di Marco, and A. Craxi Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease Aliment Pharmacol Ther 34 7 2011 757 766
66. S. Ryu, Y. Chang, S.G. Kim, J. Cho, and E. Guallar Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men Metab Clin Exp 60 6 2011 860 866
67. C. Xu, C. Yu, L. Xu, M. Miao, and Y. Li High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study PLoS One 5 7 2010 e11578
68. E. Tapia, M. Cristobal, F.E. Garcia-Arroyo, V. Soto, F. Monroy-Sanchez, U. Pacheco, and et al. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats Am J Physiol Renal Physiol 304 6 2013 F727 F736
69. Y.J. Choi, H.S. Shin, H.S. Choi, J.W. Park, I. Jo, E.S. Oh, and et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes Lab Investig 94 10 2014 1114 1125
70. M.A. Lanaspa, L.G. Sanchez-Lozada, C. Cicerchi, N. Li, C.A. Roncal-Jimenez, T. Ishimoto, and et al. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver PLoS One 7 10 2012 e47948
71. H. Kono, I. Rusyn, B.U. Bradford, H.D. Connor, R.P. Mason, and R.G. Thurman Allopurinol prevents early alcohol-induced liver injury in rats J Pharmacol Exp Ther 293 1 2000 296 303
72. H.K. Choi, K. Atkinson, E.W. Karlson, W. Willett, and G. Curhan Purine-rich foods, dairy and protein intake, and the risk of gout in men N Engl J Med 350 11 2004 1093 1103
73. R.J. Johnson, T. Nakagawa, L.G. Sanchez-Lozada, M.A. Lanaspa, Y. Tamura, K. Tanabe, and et al. Umami: the taste that drives purine intake J Rheumatol 40 11 2013 1794 1796
74. M.A. Ogryzlo Hyperuricemia induced by high fat diets and starvation Arthritis Rheum 8 5 1965 799 822
75. R.J. Johnson, M.S. Segal, Y. Sautin, T. Nakagawa, D.I. Feig, D.H. Kang, and et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease Am J Clin Nutr 86 4 2007 899 906
76. V.S. Malik, A. Pan, W.C. Willett, and F.B. Hu Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis Am J Clin Nutr 98 4 2013 1084-102
77. V.S. Malik, B.M. Popkin, G.A. Bray, J.P. Despres, W.C. Willett, and F.B. Hu Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis Diabetes Care 33 11 2010 2477 2483
78. S. Basu, P. Yoffe, N. Hills, and R.H. Lustig The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data PLoS One 8 2 2013 e57873
79. T. Ishimoto, M.A. Lanaspa, M.T. Le, G.E. Garcia, C.P. Diggle, P.S. Maclean, and et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice Proc Natl Acad Sci U S A 109 11 2012 4320 4325
80. T. Ishimoto, M.A. Lanaspa, C.J. Rivard, C.A. Roncal-Jimenez, D.J. Orlicky, C. Cicerchi, and et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase Hepatology 58 5 2013 1632 1643
81. M.A. Lanaspa, T. Ishimoto, N. Li, C. Cicerchi, D.J. Orlicky, P. Ruzicky, and et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome Nat Commun 4 2013 2434
82. L.G. Sanchez-Lozada, E. Tapia, P. Bautista-Garcia, V. Soto, C. Avila-Casado, I.P. Vega-Campos, and et al. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome Am J Physiol Renal Physiol 294 4 2008 F710 F718
83. C.L. Cox, K.L. Stanhope, J.M. Schwarz, J.L. Graham, B. Hatcher, S.C. Griffen, and et al. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women Eur J Clin Nutr 66 2 2012 201 208
84. C.L. Cox, K.L. Stanhope, J.M. Schwarz, J.L. Graham, B. Hatcher, S.C. Griffen, and et al. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans Nutr Metab (Lond) 9 1 2012 68
85. K.L. Stanhope, A.A. Bremer, V. Medici, K. Nakajima, Y. Ito, T. Nakano, and et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women J Clin Endocrinol Metab 96 10 2011 E1596 E1605
86. K.L. Stanhope, S.C. Griffen, N.L. Keim, M. Ai, S. Otokozawa, K. Nakajima, and et al. Consumption of fructose-, but not glucose-sweetened beverages produces an atherogenic lipid profile in overweight/obese men and women Diabetes 56 Suppl. 1 2007 A16 (abstr)
87. K.L. Stanhope, J.M. Schwarz, N.L. Keim, S.C. Griffen, A.A. Bremer, J.L. Graham, and et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J Clin Invest 119 5 2009 1322 1334
88. M.M. Swarbrick, K.L. Stanhope, S.S. Elliott, J.L. Graham, R.M. Krauss, M.P. Christiansen, and et al. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women Br J Nutr 2008 1 6
89. S.E. Perez-Pozo, J. Schold, T. Nakagawa, L.G. Sanchez-Lozada, R.J. Johnson, and J.L. Lillo Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response Int J Obes (Lond) 34 3 2010 454 461
90. K. Kahn, P. Serfozo, and P.A. Tipton Identification of the true product of the urate oxidase reaction J Am Chem Soc 119 23 1997 5435 5442
91. J.T. Kratzer, M.A. Lanaspa, M.N. Murphy, C. Cicerchi, C.L. Graves, P.A. Tipton, and et al. Evolutionary history and metabolic insights of ancient mammalian uricases Proc Natl Acad Sci U S A 111 10 2014 3763 3768
92. R.J. Johnson, and P. Andrews Fructose, uricase, and the back-to-Africa hypothesis Evol Anthropol 19 2010 250 257
93. R.J. Johnson, and P. Andrews The fat gene: a genetic mutation in prehistoric apes may underlie today's pandemic of obesity and diabetes Sci Am 313 2015 64 69
94. B.N. Ames, R. Cathcart, E. Schwiers, and P. Hochstein Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proc Natl Acad Sci U S A 78 11 1981 6858 6862
95. A.R. Sutin, R.G. Cutler, S. Camandola, M. Uda, N.H. Feldman, F. Cucca, and et al. Impulsivity is associated with uric acid: evidence from humans and mice Biol Psychiatry 75 1 2014 31 37
96. A.L. Gosling, E. Matisoo-Smith, and T.R. Merriman Gout in Maori Rheumatology (Oxford) 53 5 2014 773 774
97. R.J. Johnson, M.A. Lanaspa, L.G. Sanchez-Lozada, C.J. Rivard, B. Rodriguez-Iturbe, T.R. Merriman, and et al. Fat storage syndrome in Pacific peoples: a combination of environment and genetics? Public Health Dialog. 20 2014 11 16
98. M.M. Gertler, S.M. Garn, and S.A. Levine Serum uric acid in relation to age and physique in health and in coronary heart disease Ann Intern Med 34 6 1951 1421 1431
99. B.F. Culleton, M.G. Larson, W.B. Kannel, and D. Levy Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 131 1 1999 7 13
100. V. Vaccarino, and H.M. Krumholz Risk factors for cardiovascular disease: one down, many more to evaluate Ann Intern Med 131 1 1999 62 63
101. R.J. Johnson, S.D. Kivlighn, Y.G. Kim, S. Suga, and A.B. Fogo Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease Am J Kidney Dis 33 2 1999 225 234
102. R.J. Johnson, and K.R. Tuttle Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease Hypertension 35 3 2000 E10
103. A. Noman, D.S. Ang, S. Ogston, C.C. Lang, and A.D. Struthers Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial Lancet 375 9732 2010 2161 2167
104. M.P. Kao, D.S. Ang, S.J. Gandy, M.A. Nadir, J.G. Houston, C.C. Lang, and et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease J Am Soc Nephrol 22 7 2011 1382 1389
105. L. Grimaldi-Bensouda, A. Alperovitch, E. Aubrun, N. Danchin, M. Rossignol, L. Abenhaim, and et al. Impact of allopurinol on risk of myocardial infarction Ann Rheum Dis 74 5 2015 836 842
106. M. Goicoechea, S. Garcia de Vinuesa, U. Verdalles, E. Verde, N. Macias, A. Santos, and et al. Allopurinol and progression of CKD and cardiovascular events: long-term Follow-up of a randomized clinical trial Am J Kidney Dis 65 4 2015 543 549
107. A. Hoieggen, M.H. Alderman, S.E. Kjeldsen, S. Julius, R.B. Devereux, U. De Faire, and et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study Kidney Int 65 3 2004 1041 1049
108. H. Terawaki, M. Nakayama, E. Miyazawa, Y. Murata, K. Nakayama, M. Matsushima, and et al. Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study Clin Exp Nephrol 17 4 2013 549 553
109. W.S. Waring, A. Convery, V. Mishra, A. Shenkin, D.J. Webb, and S.R. Maxwell Uric acid reduces exercise-induced oxidative stress in healthy adults Clin Sci 105 4 2003 425 430
110. C. Gersch, S.P. Palii, W. Imaram, K.M. Kim, S.A. Karumanchi, A. Angerhofer, and et al. Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress Nucleosides Nucleotides Nucleic Acids 28 2 2009 118 149
111. W. Imaram, C. Gersch, K.M. Kim, R.J. Johnson, G.N. Henderson, and A. Angerhofer Radicals in the reaction between peroxynitrite and uric acid identified by electron spin resonance spectroscopy and liquid chromatography mass spectrometry Free Radic Biol Med 49 2 2010 275 281
112. A.J. Reyes, and W.P. Leary The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid? Cardiovasc Drugs Ther 16 6 2002 485 487
113. S. Reungjui, C.A. Roncal, W. Mu, T.R. Srinivas, D. Sirivongs, R.J. Johnson, and et al. Thiazide diuretics exacerbate fructose-induced metabolic syndrome J Am Soc Nephrol 18 10 2007 2724 2731
114. J. George, E. Carr, J. Davies, J.J. Belch, and A. Struthers High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 23 2006 2508 2516
115. A. Parsa, E. Brown, M.R. Weir, J.C. Fink, A.R. Shuldiner, B.D. Mitchell, and et al. Genotype-based changes in serum uric acid affect blood pressure Kidney Int 81 5 2012 502 507
116. F. Mallamaci, A. Testa, D. Leonardis, R. Tripepi, A. Pisano, B. Spoto, and et al. A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study J Hypertens 32 8 2014 1621 1628
117. F. Preitner, A. Pimentel, S. Metref, C. Berthonneche, A. Sarre, C. Moret, and et al. No development of hypertension in the hyperuricemic liver-Glut9 knockout mouse Kidney Int 87 5 2015 940 947